文献速递妇科

加速康复外科方案对妇科肿瘤微创子宫切除患者阿片类药物用量的影响

The impact of an enhanced recovery after minimally invasive surgery program on opioid use in gynecologic oncology patients undergoing hysterectomy.
PubMed 文献 · Gynecol Oncol · 2020-02-12

这项回顾性研究比较了实施微创加速康复外科(MIS-ERAS)方案前后,妇科肿瘤微创子宫切除患者的阿片类药物用量和疼痛评分。结果显示,MIS-ERAS组术中及住院期间阿片类药物用量中位数均显著低于历史对照组,疼痛评分也更低,表明该方案能有效减少围手术期阿片类药物使用。

要点

  • MIS-ERAS方案可显著降低妇科肿瘤微创子宫切除术中及术后阿片类药物用量。
  • MIS-ERAS组患者疼痛评分较历史对照组更低。
  • 多模式镇痛元素依从性≥81%,总体依从性≥75%。

核心结论

  • 实施微创加速康复外科方案可有效减少妇科肿瘤微创子宫切除患者术中及术后的阿片类药物用量。

研究设计与样本

  • 回顾性研究,比较MIS-ERAS组(n=127)与历史对照组(n=99),排除慢性阿片类药物使用或慢性疼痛患者。

主要发现

  • MIS-ERAS组术中阿片类药物用量中位数12.0 OME,低于对照组的32.0 OME(p < .0001)。
  • MIS-ERAS组住院期间术后阿片类药物用量中位数20.0 OME,低于对照组的35.0 OME(p = .02)。
  • MIS-ERAS组疼痛评分均值3.6,低于对照组的4.1(p = .03)。
  • 控制年龄、BMI、手术时间、住院时间、癌症诊断和手术方式后,MIS-ERAS组术中阿片类药物用量少10.43 OME(p < .001),术后少10.97 OME(p = .019),疼痛评分低0.56分(p = .013)。
  • 多模式镇痛元素依从性≥81%,总体依从性≥75%。

临床怎么用

  • 在妇科肿瘤微创子宫切除患者中实施MIS-ERAS方案,有助于减少围手术期阿片类药物使用并改善疼痛评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the effects of an enhanced recovery after minimally invasive surgery (MIS-ERAS) protocol on opioid requirements and post-operative pain in patients undergoing minimally invasive hysterectomy on a gynecologic oncology service. METHODS: For this retrospective study, opioid use (oral morphine equivalents (OME)) and post-operative pain scores were compared between patients undergoing minimally invasive hysterectomy pre and post MIS-ERAS protocol implementation. Patients with chronic opioid use or chronic pain were excluded. Opioid use and pain scores were compared between groups using Wilcoxon Rank Sum, Student's t-test, and multiple linear regression. Compliance and factors associated with opioid use and pain scores were assessed. RESULTS: The MIS-ERAS cohort (n = 127) was compared to the historical cohort (n = 99) with no differences in patient demographic, clinical or surgical characteristics observed between groups. Median intra-operative and inpatient post-operative opioid use were lower among the MIS-ERAS cohort (12.0 vs 32.0 OME, p < .0001 and 20.0 vs 35.0 OME, p = .02, respectively). Pain scores among MIS-ERAS patients were also lower (mean 3.6 vs 4.1, p = .03). After controlling for age, BMI, operative time, length of stay, cancer diagnosis, and surgical approach, the MIS-ERAS cohort used 10.43 fewer OME intra-operatively (p < .001), 10.97 fewer OME post-operatively (p = .019) and reported pain scores 0.56 points lower than historical controls (p = .013). Compliance was ≥81% for multimodal analgesia elements and ≥75% overall. CONCLUSIONS: Enhanced recovery after minimally invasive surgery protocol implementation is an effective means to reduce opioid use, both in the intra-operative and post-operative phases of care, among gynecologic oncology patients undergoing minimally invasive hysterectomy.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Weston E, Noel M, Douglas K, et al. The impact of an enhanced recovery after minimally invasive surgery program on opioid use in gynecologic oncology patients undergoing hysterectomy. Gynecol Oncol. 2020. PMID: 32059864. doi:10.1016/j.ygyno.2020.01.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。